Clinical Trials Sponsored by Generica Pharmaceuticals

Total 19875 results

Generian Pharmaceuticals, Inc.

Not yet recruiting

A Phase I Study of GT300 in Healthy Subjects

Lewy Body Disease
Generica Pharmaceuticals
Optimum Contract Research Organisation

Completed

Efficacy and Safety of NEM® Brand Eggshell Membrane in Patients With Grade 2/3 Knee Osteoarthritis

Osteoarthritis, Knee

Turkey
Myriad Genetic Laboratories, Inc.
Myriad Genetics, Inc.

Completed

Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes

Hereditary Cancer

United States
AO GENERIUM

Completed

Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP

Idiopathic Thrombocytopenic Purpura

Russian Federation
AO GENERIUM

Completed

Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria® (NAP)

Paroxysmal Nocturnal Hemoglobinuria

Russian Federation
AO GENERIUM

Completed

Observational Study of Elizaria® in aHUS Patients

Atypical Hemolytic Uremic Syndrome | aHUS

Russian Federation
AO GENERIUM

Completed

Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNH

Paroxysmal Nocturnal Hemoglobinuria | Marchiafava-Micheli Syndrome | Paroxysmal Hemoglobinuria

Russian Federation
AO GENERIUM

Completed

An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma (NAP)

Bronchial Asthma

Russian Federation
AO GENERIUM

Completed

Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19

COVID-19 | Coronavirus Disease 2019

Russian Federation
Identifai Genetics

Recruiting

Identifai Genetics Analytic Validity Study - Compound Heterozygosity and Samples Collection

Genetics | Prenatal Diagnosis

United States
Luna Genetics

Recruiting

Cell-Based Noninvasive Prenatal Testing (NIPT)

Pregnancy Related

United States
AO GENERIUM

Recruiting

A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II

Metabolic Diseases | Mucopolysaccharidosis Type II

Russian Federation
AO GENERIUM

Recruiting

Efficacy, Safety, pharmacokinetiсs, Immunogenicity of GNR-067 and Lucentis® (NAP)

Age Related Macular Degeneration (ARMD)

Russian Federation
AO GENERIUM

Active, not recruiting

A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

Melanoma | Carcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung

Russian Federation
AO GENERIUM

Enrolling by invitation

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

Idiopathic Thrombocytopenic Purpura

Russian Federation
Luna Genetics

Completed

Cell- Based Noninvasive Prenatal Testing (NIPT): Single Cell Prenatal Diagnosis (SCPD) (NIPT & SCPD)

Pregnancy Related

United States
Ambry Genetics

Completed

Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer

Breast Cancer Risk

United States
AO GENERIUM

Completed

A Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC "GENERIUM", Russian Federation) (NAP)

Paroxysmal Nocturnal Hemoglobinuria

Russian Federation
AO GENERIUM

Completed

Study of Pharmacokinetics, Pharmacodynamics and Safety Assessment of GNR-044 (JSC GENERIUM, Russia) and Xolair® (NAP)

Healthy Volunteers

Russian Federation
Corautus Genetics

Unknown

To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given With an Experimental Injection Catheter

Angina Pectoris

United States
AO GENERIUM

Recruiting

Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction

ST Elevation Myocardial Infarction

Russian Federation
AO GENERIUM

Recruiting

GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL

ALL | B-precursor Acute Lymphoblastic Leukemia | GNR-084

Russian Federation
AO GENERIUM

Withdrawn

Efficacy and Safety of GNR-038 vs Berinert® in Patients With Hereditary Angioedema

Hereditary Angioedema

Russian Federation
AO GENERIUM

Completed

A Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers

Metabolic Diseases | Mucopolysaccharidosis Type II

Russian Federation
AO GENERIUM

Completed

Safety and Pharmacokinetics of GNR-038 in Healthy Volunteers

Hereditary Angioedema

Russian Federation
AO GENERIUM

Completed

Efficacy and Safety of Tigerase® vs. Pulmozyme® in Patients With Cystic Fibrosis

Fibrosis | Cystic Fibrosis

Russian Federation
Previvo Genetics

Unknown

Controlled Ovarian Stimulation and Human Uterine Lavage

Infertility, Female

Mexico
Genetic Immunity

Completed

Single DermaVir Immunization in HIV-1 Infected Patients on HAART (GIHU004)

HIV Infection

Hungary
Greenwood Genetic Center
Shriners Hospitals for Children; BioMarin Pharmaceutical

Completed

Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome

MPS IVA | Maroteaux Lamy Syndrome | MPS VI | Morquio Syndrome A

United States
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Sophia Genetics SAS

Recruiting

Predictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung Cancer (DEEP-Lung-IV)

Non-small Cell Lung Cancer Metastatic

United States, Spain, France, Israel, Germany, Canada, Italy, Brazil
Future Genetics Limited

Recruiting

EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality

Depression | Cardiovascular Diseases | Heart Failure | Epilepsy | Hypertension | Obesity | Diabetes Mellitus | Cancer | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Rheumatoid Arthritis | Peripheral Arterial Disease | Atrial Fibrillation | Asthma | Dementia | Blood Pressure | Coronary Heart Disease | Mental... and other conditions

United Kingdom
Future Genetics Limited

Withdrawn

EMPOWER - BAME vs COVID

Health Disparities | COVID-19, SARS-CoV 2 Infection

United Kingdom
Targeted Genetics Corporation

Completed

Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94

Rheumatoid Arthritis

Canada, United States
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Opus Genetics, Inc

Recruiting

Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD)

LCA5

United States
Vanilloid Genetics Inc.

Unknown

Neuropeptide Therapy of Recent Onset Type 1 Diabetes

Diabetes Mellitus, Type 1

Canada
Targeted Genetics Corporation

Completed

Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

Arthritis, Rheumatoid | Arthritis, Psoriatic | Ankylosing Spondylitis

United States
Interleukin Genetics, Inc.

Unknown

A to Z Study Follow-up: Collection of DNA Data From Buccal Swabs

Obesity | Weight Management | Dietary Recommendations | Diet Conditions | Overweight Management

United States
Interleukin Genetics, Inc.

Completed

Identification of Gene Biomarkers in Aging Skin

Hyperpigmentation | Skin Aging

Japan
Icon Genetics GmbH

Completed

Autologous Vaccine for Follicular Lymphoma

Lymphoma, Follicular

United States
Interleukin Genetics, Inc.

Completed

Association of Genes to Resistance to Weight Loss in Obese Patients

Obesity | Metabolic Syndrome | Dyslipidemia

United States
Genetic Disease Investigators

Not yet recruiting

Neurological Dry Eye Study Stimulating Both Lacrimal and Vagus Nerves

Dry Eye | Dry Eye Disease
Genetic Disease Investigators

Withdrawn

Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life

Multiple Sclerosis

United States
Novartis Pharmaceuticals
Pharmaceutical Research Associates

Withdrawn

Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants

Renal Impairment
Novartis Pharmaceuticals
Pharmaceutical Research Associates

Withdrawn

Pharmacokinetics of TNO155 in Participants With Mild, Moderate, or Severe Hepatic Impairment Compared to Matched Healthy Participants

Hepatic Impairment
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Completed

Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip (FACT OA2)

Osteoarthritis, Knee | Osteoarthritis, Hip

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment

Chronic HBV Infection

Hong Kong, Taiwan
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Terminated

Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee (FACT CLBP 1)

Osteoarthritis | Chronic Low Back Pain

United States

Clinical Trials Sponsored by Generica Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations